Safety and Efficacy of Nasogastric Tube Placement Prior to Long Tube Placement for the Conservative Management of Adhesive Small Bowel Obstruction: A Retrospective Analysis Authors: Sakuya Katakai, Kengo Kasuga, Tatsuya Kouga, Ayaki Isshiki, Ayako Matsui, Keisuke Iizuka, Shingo Ishihara, Takashi Ueno, Xing Hua Ma, Takashige Masuo, Yoji Takeuchi, Toshio Uraoka Published: 2026 ABSTRACT AbstractObjective: Adhesive small bowel obstruction (ASBO) without strangulation or ischemia is typically treated conservatively. Compared to nasogastric tube (NGT) placement, long tube (LT) placement has shown lower surgery rates, but it is more invasive and may be poorly tolerated in frail patients. This study evaluated the safety and efficacy of initial NGT placement followed by LT placement in ASBO. Methods: We retrospectively analyzed 337 ASBO-related admissions between 2019 and 2023. Analyses were performed on an admission-level basis. After exclusions, admissions were categorized into the NGT group (initial NGT placement, n=135), and the LT group (initial LT placement, n=60). Admissions requiring LT placement after NGT placement were defined as the NGT+LT group (n=63). Clinical characteristics, treatment outcomes, and adverse events were compared between groups. Results: Admissions in the NGT group involved older patients and a poorer performance status than the LT group; similar differences were observed between the NGT+LT and LT groups. LT placement time was significantly shorter in the NGT+LT group compared with the LT group (18 vs. 24 minutes, p < 0.001). No statistically significant differences were observed between the NGT+LT and LT groups in surgery rates (13% vs. 12%), hospital stay, mortality, or adverse events. In admissions treated with NGT alone, the surgery rate was 4%, and clinical outcomes were favorable. Conclusions: Initial NGT placement followed by selective LT insertion appears to be a reasonable stepwise treatment strategy in real-world clinical practice, associated with a lower proportion of admissions requiring LT placement and shorter LT insertion time. Keywords: adhesive small bowel obstruction, nasogastric tube, long tube, conservative management INTRODUCTION Adhesive small bowel obstruction (ASBO) is a common disease, accounting for 74% of all cases of small bowel obstruction[1]. Since the surgical release of adhesions can result in subsequent adhesions[2], non-operative management is recommended for ASBO without strangulation or ischemia[3]. In particular, non-operative decompression with nasogastric tube (NGT) or long tube (LT) placement is reportedly effective in 46.7% to 91.1% of patients with ASBO[3-11]. Although lower surgery rates are seen with LT placement compared with NGT placement[11], the former is more invasive (time-consuming, labor-intensive, and technically demanding) and carries a risk of complications such as pneumonia and persistent nasal and pharyngeal discomfort due to its stiffer material and longer insertion length. It may also cause nasopharyngeal injury. Thus, patients with ASBO may be reluctant to undergo LT placement. Although NGT placement has not been reported to reduce the risk of pneumonia[12], it can improve systemic inflammation[8] and is less invasive, making it easy to insert even at the bedside. Therefore, NGT placement is a viable option for initial treatment. Furthermore, even when subsequent placement of an LT is required after NGT placement, the gastric contents are removed with NGT, which may reduce the risk of pneumonia and shorten the time needed for subsequent LT placement. This study aimed to evaluate the safety and efficacy of initial NGT placement followed by LT placement in patients with ASBO. METHODS Patients and ethics The study included 337 ASBO-related admissions to Isesaki Municipal Hospital between January 2019 and December 2023. During the study period, 218 patients experienced multiple ASBO-related admissions; therefore, all analyses were conducted on an event (admission)-level basis, and data were collected separately for each hospitalization. The inclusion criteria were as follows: (i) clinical symptoms caused by intestinal obstruction (i.e., abdominal pain, nausea, vomiting), (ii) intestinal obstruction diagnosed based on computed tomography (CT), (iii) no evidence of intestinal strangulation, ischemia, tumor, or hernia on CT. The exclusion criteria were as follows: patients (i) whose ASBO resolved spontaneously without NGT/LT insertion, (ii) with previous total gastrectomy, (iii) with previous abdominal surgery within 1 month, (iv) without endoscopy being used at the time of LT placement, (v) with insufficient data, (vi) who had LT inserted at another hospital, (vii) without a history of previous abdominal surgery, and (viii) without a CT scan. This study was approved by the ethical review board of Isesaki Municipal Hospital (approval number 2023-52). Consent from participants was obtained through an opt-out method on the institution's website. Instrument and procedures For the LTs, hydrophilic ileus tubes made of silicone rubber (CLINY ES NT wire set, Create Medic, Kanagawa, Japan) were used; these are 300 cm long, 16 Fr, and have three channels (valve for indwelling balloon, air vent, and suction port) and two balloons (tip balloon and indwelling balloon), as well as two side holes and six suction holes at the tip. For LT insertion, first, an ultra-slim gastroscope was inserted into the stomach through the nose, and the stomach contents were aspirated as much as possible. Then, the gastroscope was advanced to the duodenum. Afterward, a 0.052-inch guidewire (Hydrophilic Ni-Ti guidewire; Create Medic, Kanagawa, Japan) was advanced and kept in the duodenum through the accessory channel of the ultra-slim gastroscope after withdrawal of the gastroscope under fluoroscopic guidance. The LT was then advanced into the small intestine using a guide wire and placed. The LT was inserted as deeply as possible without causing significant pain or prolonged treatment, and was advanced at least to the point presumed to have passed the ligament of Treitz. The inserted LT was removed after confirmation of improvement in ASBO. For the NGTs, double-lumen nasogastric tube made of polyvinyl chloride (Salem Sump™, Cardinal Health, Tokyo, Japan) was used; these are 120 cm long, 16 Fr, and has a non-return valve. The NGT was inserted through either nasal cavity, and after insertion, abdominal radiographs confirmed that the tip of the NGT was retained in the stomach. There were no strict criteria for selecting the method of intestinal decompression; decisions were generally made according to the following principles. No decompression: Patients who had no or minimal abdominal pain or vomiting regardless of the time of arrival, and with CT finding showing only mild stomach and small intestine distension. NGT insertion: i) Patients who present during daytime hours with abdominal pain and vomiting, those with CT findings of stomach and small intestine dilation; patients scheduled for LT insertion who required temporary decompression before the procedure, or ii) patients presenting at nighttime hours with abdominal pain and vomiting but without persistent pain despite analgesic administration. LT insertion: i) Patients presenting during daytime hours with severe small bowel distension on CT, or ii) those presenting at nighttime hours with persistent pain despite analgesic administration. When patients strongly refused tube placement, decompression was withheld, or treatment was initiated with NGT insertion rather than LT. Switching from NGT to LT placement was considered when no clinical or radiological improvement occurred after initial decompression, defined by persistent absence of defecation or flatus and ongoing small bowel dilatation without colonic gas on abdominal radiography, usually assessed within 1–2 days after NGT placement. Data collection and definition of relevant factors The following data were extracted from the patient's medical records: age, sex, history of abdominal surgery, surgery type, history of abdominal radiation, history of ASBO, performance status (PS) [Eastern Cooperative Oncology Group], symptoms upon admission, vital signs (i.e., temperature, systolic blood pressure, pulse), laboratory data (i.e., white blood cell count, hemoglobin, platelet count, total protein, blood urea nitrogen, creatinine, C-reactive protein), presence of ascites on CT, use of water-soluble contrast after NGT insertion, LT placement date, LT placement time (time from endoscope insertion to securing the LT), LT placement distance, adverse events related to LT/NGT, surgery date, surgery rate, duration of LT placement, duration of fasting, hospital length of stay, mortality, and reason for changing from NGT to LT. Admissions were classified into the NGT group if NGT was used as the initial decompression method, regardless of subsequent LT placement. Admissions requiring LT placement after initial NGT insertion were classified as the NGT+LT group, and those receiving LT as the initial treatment were classified as the LT group. Daytime (8:30–17:15) and nighttime (17:15–8:30 of the following day) were defined based on the working hours of the hospital. Holidays were defined as Saturdays, Sundays, and Japanese national holidays. Statistical analysis Statistical analysis was performed with the IBM SPSS Statistics for Windows (version 31.0; Tokyo, Japan). Categorical and continuous variables were analyzed and compared using Pearson's chi-square test and Student's t-test, respectively. Two-tailed p values < 0.05 were considered statistically significant. To adjust for baseline differences between groups, multivariable logistic regression analysis was performed to evaluate factors associated with surgical intervention. Variables considered clinically relevant, including age, PS (0–2 vs. 3–4), abdominal pain, and ascites on CT, were included in the model. Furthermore, a sensitivity analysis restricted to first admissions per patient was performed to account for potential clustering due to repeated admissions. RESULTS Clinical characteristics of ASBO-related admissions The study flowchart is shown in Figure 1. Initially, 337 ASBO-related admissions were identified, and after applying the exclusion criteria, 195 admissions were included in the analysis. These admissions were classified into the NGT group (n = 135) and the LT group (n = 60), and their baseline characteristics and clinical findings are shown in Table 1. Admissions in the NGT group involved older patients (76 vs. 72 years, 95% CI 0.146 to 9.261; p = 0.04), a higher proportion with PS 3–4 (13% vs. 1.7%, OR 7.556, 95% CI 1.029 to 55.479; p = 0.01), and a lower frequency of nausea (49% vs. 72%, OR 0.682, 95% CI 0.539 to 0.863; p < 0.001) compared with those in the LT group. Among the 135 admissions initially managed with NGT, 72 admissions were treated with NGT alone, whereas 63 admissions required subsequent LT placement after a mean of 1.4 days of NGT decompression. Among admissions treated with NGT alone, surgical conversion occurred in three admissions (4%), with a median hospital stay of 9 days. Two deaths (2.7%) occurred, both in admissions involving patients with poor general condition (PS 4), in whom LT placement or surgery was considered difficult. Subsequently, admissions in the NGT+LT group (n = 63) were compared with those in the LT group (n = 60) (Table 2). Admissions in the NGT+LT group involved older patients (78 vs. 72 years, 95% CI 1.276 to 11.315; p = 0.01), a higher proportion with PS 3–4 (16% vs. 1.7%, OR 9.524, 95% CI 1.257 to 72.153; p = 0.006), less frequent abdominal pain (71% vs. 90%, OR 0.794, 95% CI 0.665 to 0.948; p = 0.009), and lower total protein levels (7.1 vs. 7.4 g/dL, 95% CI -0.536 to -0.027; p = 0.03). No admissions received water-soluble contrast after NGT placement. Multivariable logistic regression analysis showed that treatment strategy was not independently associated with surgical intervention. The detailed results of the multivariable analysis are presented in Tables 3, 44. Compared with the LT group, the NGT group was not significantly associated with the risk of surgery (OR 1.52, 95% CI 0.52 to 4.44). Similarly, outcomes were comparable between the NGT+LT and LT groups (OR 0.95, 95% CI 0.30 to 2.99). None of the covariates included in the model were significantly associated with surgical intervention. A sensitivity analysis excluding second or subsequent admissions was performed. After restriction to first admissions, baseline differences in age and total protein were attenuated, although the numerical trend persisted. Differences in PS remained significant, with a poorer PS in the NGT and NGT+LT groups. Symptom profiles were also generally consistent with the primary analysis. Nausea remained more frequent in the NGT group than in the LT group (48% vs. 71%, p = 0.01), and abdominal pain remained less frequent in the NGT+LT group than in the LT group (71% vs. 91%, p = 0.02). LT placement time remained significantly shorter in the NGT+LT group (median 19 min vs. 23 min, p < 0.001), confirming the robustness of this finding. In contrast, differences in overall surgery rates were no longer statistically significant between the NGT+LT and LT groups, although the numerical trend toward lower surgery rates in the NGT-based strategy persisted (7.1% vs. 16%). Notably, when comparing the NGT group with the LT group, the surgery rate was significantly lower in the NGT group (4.2% vs. 16%, p = 0.02). Study flow chart. Table 1.Baseline Characteristics and Clinical Findings of Admissions with Adhesive Small Bowel Obstruction.NGT groupLT groupp valueNumber of admissions13560NAAge (years), median [IQR]76 [65–83]72 [59–79]0.04Sex, Male/Female n, (%)76 (56%)/59 (44%)31 (52%)/29 (48%)0.55Previous abdominal surgery, n (%)Gastric surgery36 (27%)14 (23%)0.62Colorectal surgery68 (50%)29 (48%)0.79Small bowel surgery15 (11%)7 (12%)0.91Hepatobiliary or pancreatic surgery17 (13%)10 (17%)0.45Gynecological surgery36 (27%)16 (27%)1.00Urological surgery13 (10%)9 (15%)0.27Other6 (4.4%)2 (3.3%)0.72History of abdominal radiation, n (%)2 (1.5%)1 (1.7%)0.92History of ASBO, n (%)67 (50%)27 (45%)0.55History of surgery for ASBO, n (%)5 (3.7%)4 (6.7%)0.36Performance status 3 or 4, n (%)17 (13%)1 (1.7%)0.01Symptoms on admission, n (%)Abdominal pain107 (79%)54 (90%)0.07Nausea66 (49%)43 (72%)0.003Vomiting79 (59%)36 (60%)0.85Vital signs, median [IQR]Temperature (℃)36.7 [36.3–37.0]36.7 [36.4–36.9]0.70Systolic blood pressure (mmHg)134 [119–154]135 [120–156]0.53Pulse (/min)83 [72–98]89 [81–98]0.29Laboratory data, median [IQR]White blood cell (/μL)9400 [6900–12150]8700 [7200–12200]0.64Hemoglobin (g/dL)13.6 [12.4–14.9]13.6 [12.8–15.0]0.40Blood platelet (10^4/μL)23.2 [19.2–28.3]23.1 [19.1–26.7]0.54Total protein (g/dL)7.3 [6.9–7.8]7.4 [7.0–7.8]0.47Blood urea nitrogen (mg/dL)19 [15–26]18 [13–24]0.84Creatinine (mg/dL)0.82 [0.63–1.11]0.82 [0.68–1.05]0.36C-reactive protein (mg/dL)0.25 [0.25–0.96]0.26 [0.25–0.89]0.90Ascites, n (%)0.33No89 (66%)24 (40%)Yes; Douglas fossa only26 (19%)23 (38%)Yes; Beyond the Douglas fossa20 (15%)13 (22%)Adverse event related to NGT, n (%)1 (0.7%)Surgery rate, n (%)11 (8.1%)7 (12%)0.43Duration of NGT placement (day), median [IQR]2 [1–3]Duration of fasting (day), median [IQR]5 [4–7]6 [5–9]0.34Hospital length of stay (day), median [IQR]10 [7–14]10.5 [7–15.25]0.72Mortality, n (%)4 (3.0%)1 (1.6%)0.60NGT; nasogastric tube, LT; long tube, ASBO; adhesive small bowel obstruction; IQR; interquartile rangeNGT group: NGT placement done as initial treatment regardless of whether LT insertion was subsequently performed; LT group: LT placement done as initial treatment Baseline Characteristics and Clinical Findings of Admissions with Adhesive Small Bowel Obstruction. NGT; nasogastric tube, LT; long tube, ASBO; adhesive small bowel obstruction; IQR; interquartile range NGT group: NGT placement done as initial treatment regardless of whether LT insertion was subsequently performed; LT group: LT placement done as initial treatment Table 2.Baseline Characteristics and Clinical Findings of Admissions with Adhesive Small Bowel Obstruction Treated with NGT+LT or LT.NGT+LT groupLT groupp valueNumber of admissions6360NAAge (years), median [IQR]78 [69–84]72 [59–79]0.01Sex, Male/Female n, (%)39 (62%)/24 (38%)31 (52%)/29 (48%)0.26Surgery type, n (%)Gastric surgery22 (35%)14 (23%)0.16Colorectal surgery35 (56%)29 (48%)0.42Small bowel surgery10 (16%)7 (12%)0.50Hepatobiliary or pancreatic surgery11 (17%)10 (17%)0.90Gynecological surgery13 (21%)16 (27%)0.43Urological surgery7 (11%)9 (15%)0.52Other3 (4.8%)2 (3.3%)0.69History of abdominal radiation, n (%)1 (1.5%)1 (1.7%)0.97History of ASBO, n (%)27 (43%)27 (45%)0.81History of surgery for ASBO, n (%)2 (3.2%)4 (6.7%)0.37Performance status 3 or 4, n (%)10 (16%)1 (1.7%)0.006Previous abdominal surgery, n (%)Abdominal pain45 (71%)54 (90%)0.009Nausea47 (75%)43 (72%)0.71Vomiting40 (63%)36 (60%)0.69Vital signs, median [IQR]Temperature (℃)36.7 [36.5–37.0]36.7 [36.4–36.9]0.30Systolic blood pressure (mmHg)131 [119–156]135 [120–156]0.56Pulse (/min)80 [72–95]89 [81–98]0.06Laboratory data, median [IQR]White blood cell (/μL)8600 [6600–10800]8700 [7200–12200]0.57Hemoglobin (g/dL)13.7 [12.2–14.9]13.6 [12.8–15.0]0.27Blood platelet (10^4/μL)24.1 [20.2–28.4]23.1 [19.1–26.7]0.86Total protein (g/dL)7.1 [6.7–7.6]7.4 [7.0–7.8]0.03Blood urea nitrogen (mg/dL)19 [15–28]18 [13–24]0.70Creatinine (mg/dL)0.81 [0.63–1.18]0.82 [0.68–1.05]0.42C-reactive protein (mg/dL)0.26 [0.25–1.77]0.26 [0.25–0.89]0.15Ascites, n (%)0.84No27 (43%)24 (40%)Yes; Douglas fossa only19 (30%)23 (38%)Yes; Beyond the Douglas fossa17 (27%)13 (22%)NGT; nasogastric tube, LT; long tube, ASBO; adhesive small bowel obstruction; IQR; interquartile rangeNGT+LT group: NGT insertion prior to LT placement; LT group: LT placement done as initial treatment Baseline Characteristics and Clinical Findings of Admissions with Adhesive Small Bowel Obstruction Treated with NGT+LT or LT. NGT; nasogastric tube, LT; long tube, ASBO; adhesive small bowel obstruction; IQR; interquartile range NGT+LT group: NGT insertion prior to LT placement; LT group: LT placement done as initial treatment Table 3.Multivariable Logistic Regression Analysis for Surgical Intervention: Comparison between NGT and LT Groups.VariableOR95% CIp-valueNGT group vs LT group1.520.05–4.440.45Age1.000.96–1.030.84Performance status 3 or 40.510.05–4.880.56Abdominal pain0.470.13–1.760.26Ascites on CT1.520.54–4.300.43NGT; nasogastric tube, LT; long tubeNGT group: NGT placement done as initial treatment regardless of whether LT insertion was subsequently performed; LT group: LT placement done as initial treatment; NGT+LT group: NGT insertion prior to LT placement Multivariable Logistic Regression Analysis for Surgical Intervention: Comparison between NGT and LT Groups. NGT; nasogastric tube, LT; long tube NGT group: NGT placement done as initial treatment regardless of whether LT insertion was subsequently performed; LT group: LT placement done as initial treatment; NGT+LT group: NGT insertion prior to LT placement Table 4.Multivariable Logistic Regression Analysis for Surgical Intervention: Comparison between NGT + LT and LT Groups.VariableOR95% CIp-valueNGT+LT group vs LT group0.950.30–2.990.93Age1.000.96–1.040.95Performance status 3 or 40.450.04–4.660.50Abdominal pain0.500.12–2.070.34Ascites on CT1.200.38–3.800.76NGT; nasogastric tube, LT; long tubeNGT group: NGT placement done as initial treatment regardless of whether LT insertion was subsequently performed; LT group: LT placement done as initial treatment; NGT+LT group: NGT insertion prior to LT placement Multivariable Logistic Regression Analysis for Surgical Intervention: Comparison between NGT + LT and LT Groups. NGT; nasogastric tube, LT; long tube NGT group: NGT placement done as initial treatment regardless of whether LT insertion was subsequently performed; LT group: LT placement done as initial treatment; NGT+LT group: NGT insertion prior to LT placement Therapeutic efficacy The treatment outcomes are shown in Table 5. LT placement was within an average of 1.4 days after NGT placement in the NGT+LT group. LT placement time was significantly shorter in the NGT+LT group (18 vs. 24 min, 95% CI -9.57 to -3.842; p < 0.001). Table 5.The Treatment Outcomes of Adhesive Small Bowel Obstruction Treated with NGT+LT or LT.NGT+LT groupLT groupp–valueNumber of admissions6360NALT placement date (day), mean1.41.20.13LT placement time (min), median [IQR]18 [16–22]24 [20–30]< 0.001LT placement distance (cm), median [IQR]145 [133–160]142.5 [125–171.25]0.44Adverse event related to LT, n (%)Pneumonia1 (1.5%)3 (5%)0.29Gastrointestinal perforation1 (1.5%)0 (0%)0.33Adverse event related to NGT, n (%)0 (0%)Surgery rate, n (%)8 (13%)7 (12%)0.86Duration of LT placement (day), median [IQR]5 [3–6]5 [4–7]0.39Duration of fasting (day), median [IQR]6 [5–8]6 [5–9]0.43Hospital length of stay (day), median [IQR]11 [9–16]10.5 [7–15.25]0.23Mortality, n (%)2 (3.2%)1 (1.6%)0.59NGT; nasogastric tube, LT; long tubeNGT+LT group: NGT insertion prior to LT placement; LT group: LT placement done as initial treatment The Treatment Outcomes of Adhesive Small Bowel Obstruction Treated with NGT+LT or LT. NGT; nasogastric tube, LT; long tube NGT+LT group: NGT insertion prior to LT placement; LT group: LT placement done as initial treatment The adverse events for LT placement included pneumonia (NGT+LT group, n = 1; LT group, n = 3) and gastrointestinal perforation (NGT+LT group, n = 1), with no significant differences between the two groups. The admission complicated by pneumonia in the NGT+LT group was discharged on day 15 after treatment with antimicrobial agents, while the admission complicated by gastrointestinal perforation was discharged on day 14 after emergency surgery for the perforation. Admissions complicated by pneumonia in the LT group were discharged on days 12, 13, and 17 after antimicrobial therapy, respectively. No adverse events occurred during NGT placement. When comparing the NGT+LT and LT groups, prior NGT placement did not increase the incidence of complications, with no significant difference in the incidence of pneumonia. There were two mortalities in the NGT+LT group (i.e., aspiration pneumonia and exacerbation of acute renal failure, both present at the time of admission), but neither was related to the choice of bowel decompression method. There was one mortality in the LT group, due to worsening aspiration pneumonia that developed during hospitalization. There were no significant differences in mortality between the two groups. Pneumothorax and mediastinal emphysema were not observed in this cohort. In addition, intussusception of the small intestine, a known adverse event of LT placement[13], was not observed. There were no significant differences between the two groups in terms of LT placement distance, surgery rate, time until LT placement, duration of fasting, or number of hospital days. In the NGT+LT and LT groups, respectively, surgery was done in 8 and 7 admissions after an average of 7 and 6 days from LT placement. Reason for NGT placement Table 6 shows the reasons for NGT placement, which included the following: visited the hospital at nighttime or during a holiday (52%, 33/63); visited at daytime, but decompression was performed during preparation for endoscopy (38%, 24/63); and because of the expected therapeutic response with an NGT only (10%, 6/63). Among admissions managed initially with NGT for its expected therapeutic effect, LT placement was subsequently required on hospital day 1 (n = 1) or day 2 (n = 5) because of lack of improvement on clinical and abdominal radiography. Table 6.The Reason for Nasogastric Tube Placement.Visit time was nighttime or a holiday, n (%)33 (52%)Visit time was daytime, but performed bowel decompression until ready for endoscopy, n (%)24 (38%)Because of the expected therapeutic response with a nasogastric tube only, n (%)6 (10%) The Reason for Nasogastric Tube Placement. DISCUSSION This single-center, retrospective study demonstrated that a stepwise decompression strategy using initial NGT placement followed by selective LT placement is safe and effective for ASBO-related admissions. NGT placement was preferentially selected for admissions involving elderly patients, those with poor PS, or relatively mild symptoms, and nearly half of these admissions resolved without the need for LT placement. LT placement was subsequently added when clinical improvement was not achieved, typically in admissions involving more severe conditions. Despite differences in baseline characteristics, there were no statistically significant differences in outcomes between admissions managed with NGT followed by LT and those managed with initial LT placement, including hospital length of stay, surgery rate, and mortality. Notably, prior NGT placement significantly reduced LT insertion time. These findings suggest that a stepwise decompression approach may be reasonable in real-world clinical practice. In our study, the rate of transition to surgery was lower than in previous studies, in which surgery rates ranged from 10.4%–34.3% with LT placement[8,10,11] and 8.9%–53.3% with NGT insertion alone[8-12]. Some admissions with minimal abdominal symptoms were managed without bowel decompression, indicating that NGT and LT placement were mainly performed in more severe cases, differing from previous randomized controlled trials[10,11]. However, the surgery rates remained low in admissions managed with NGT placement with or without LT placement (8%, 11/135), as well as in those who underwent LT placement as initial treatment (12%, 7/60). In our study, there was no significant difference in surgery rates between admission managed with NGT placement alone and those treated with LT placement alone (4% vs. 12%, p = 0.09). By contrast, previous studies have reported higher surgery rates with NGT-based strategies alone[10]; however, selective conversion from NGT to LT appeared not significantly different, suggesting that a stepwise decompression approach may be safely implemented in selected patients with ASBO. Previous studies recommend a waiting period of 72 hours or less for surgery[6,14-16], but in this study, the median waiting period was 7 and 6 days in NGT+LT and LT groups, respectively. This discrepancy may reflect differences in clinical practice between Western countries and Japan. In many Western settings, conservative treatment relies mainly on NGT placement, whereas LTs are more widely used in Japan to achieve more distal and effective decompression. Such intensive decompression might relieve pain, reduce bowel wall edema, restore motility, and promote spontaneous resolution of obstruction, allowing a longer observation period before surgery. Importantly, despite the prolonged duration of conservative management in the present cohort, the observed surgery rates and mortality were generally within the range reported in previous studies and guideline-based analyses[3,6,8-12,15]. In particular, mortality was 3.2% in the NGT+LT group and 1.6% in the LT group, which are comparable to the previously reported rates of approximately 0–3%[3,6,10,15]. Nevertheless, because of the retrospective design, non-randomized treatment allocation, and potential selection bias, these findings should not be interpreted as demonstrating that delayed surgical intervention is universally safe or preferable. Rather, they suggest that, in carefully selected patients undergoing intensive decompression strategies, an extended trial of non-operative management may be feasible without an apparent increase in adverse outcomes. Further prospective studies are warranted to determine the optimal timing of surgical intervention across different healthcare settings and treatment paradigms. The backgrounds of these comparisons differ; for instance, admissions in the NGT+LT group involved less abdominal pain compared with the LT group. This may reflect our strategy of selecting LT as initial treatment to ensure bowel decompression in admissions with severe pain. In addition, admissions initially managed with LT placement had significantly higher total protein, whereas no significant difference was found between the NGT and LT groups. Katano et al. reported that high total protein was a predictor of treatment failure in the NGT with water-soluble contrast strategy[10]. Although the reason is unclear, we also diagnosed more severe cases among admissions with high total protein levels and therefore selected LT as the initial treatment. Given these differences in baseline characteristics, it remains unclear whether NGT placement should precede treatment in all cases. In addition, we performed multivariable logistic regression analysis to adjust for baseline differences between treatment groups. Treatment strategy was not identified as an independent predictor of surgical intervention after adjustment for clinically relevant factors, including age, PS, abdominal pain, and ascites on CT. Although LT placement tended to be selected for patients with more severe clinical presentations, these findings suggest that a stepwise decompression approach using initial NGT placement does not increase the risk of surgery. However, the wide confidence intervals indicate limited statistical power, and residual confounding related to the non-randomized treatment selection cannot be excluded. A sensitivity analysis restricted to first admissions provided additional insight into potential selection bias. Differences in PS between treatment strategies remained evident, with a poorer PS more frequently observed in admissions initially managed with NGT-based approaches. In this restricted cohort, the surgery rate was significantly lower in the NGT group than in the LT group, which may reflect a higher threshold for surgical intervention in frailer patients rather than a direct treatment effect. Importantly, the shorter LT placement time associated with the NGT+LT strategy remained statistically significant, supporting the robustness of this procedural advantage. Although statistical significance was attenuated for several secondary outcomes due to reduced sample size, the overall direction of effect was unchanged. Importantly, although admissions in the NGT+LT group involved older patients and a poorer PS, clinical outcomes were not significantly different. Notably, the time required for LT placement was shorter in the NGT+LT group. The use of an ultra-slim gastroscope during LT placement has been reported to reduce insertion time[17,18], and in this study, LT placement was performed with an ultra-slim gastroscope in all cases. Additionally, more than half of admissions initially managed with NGT placement did not require an additional LT placement. Our findings suggest that an initial approach with NGT placement was associated with a lower proportion of admissions requiring subsequent LT placement and with shorter LT insertion time, even in frail populations. However, given the retrospective design and potential selection bias, these observations should be interpreted with caution, particularly in patients with severe small bowel distension on CT, or persistent pain despite analgesic administration. This study also has some limitations. It was a single-center, retrospective study with potential selection bias and a limited sample size. In addition, admission-level analyses may not fully account for within-patient correlations. Furthermore, long-term outcomes after discharge, including recurrence rates by intestinal decompression method, remain unclear. In this retrospective single-center cohort, an initial approach using NGT placement followed by selective LT insertion was associated with a lower proportion of admissions requiring LT placement and shorter LT insertion time. These findings may help inform real-world decision-making in selected patients, although confirmation in prospective studies is warranted. Authors' contributions Conception and design: Sakuya Katakai, Kengo Kasuga, Shingo Ishihara and Takashige Masuo; analysis and interpretation of data: Sakuya Katakai, and Kengo Kasuga; drafting of the manuscript: Sakuya Katakai, and Kengo Kasuga; acquisition of data: Sakuya Katakai, Kengo Kasuga, Ayaki Isshiki, Shingo Ishihara, and Takashige Masuo; statistical analysis: Sakuya Katakai; revision of the manuscript: Sakuya Katakai, Kengo Kasuga, Shingo Ishihara, Yoji Takeuchi, Toshio Uraoka. All authors have contributed substantially to the design, data collection and analysis, and editing of the manuscript. Approval by Institutional Review Board (IRB) This consent procedure was reviewed and approved by the ethical review board of Isesaki Municipal Hospital (approval number: 2023-52). Disclaimer Yoji Takeuchi is one of the Associate Editors of Journal of the Anus, Rectum and Colon and on the journal's Editorial Board. He was not involved in the editorial evaluation or decision to accept this article for publication at all. Availability of data and materials The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request. Conflicts of Interest Yoji Takeuchi is an Associate Editor of the Journal of the Anus, Rectum and Colon. The other authors declare no conflicts of interest. Acknowledgment The authors would like to thank Enago (www.enago.jp) for the English language review. Funding Statement This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. References